Got $1,000? 2 No-Brainer Stocks to Buy
Sometimes it's hard to know which stocks to pick amid the dozens of options available on equity markets. But occasionally, some companies look so attractive that the decision isn't so difficult. Typically, they boast excellent track records, solid economic moats, and plenty of growth potential.
Let's look at two stocks that fit this description: Vertex Pharmaceuticals (NASDAQ: VRTX) and Visa (NYSE: V). For those with $1,000 to spare -- that's not being saved for a rainy day -- let's find out why putting that money to work by investing in these companies would be a brilliant move.
One of the keys to success as a biotech company is to develop medicines for diseases that are at least as good as the existing standards of care. Vertex Pharmaceuticals' goal goes further. The drugmaker focuses primarily on developing therapies for illnesses where there are no treatment options, or at least where there aren't any that treat the underlying causes of the disease in question.
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
Die Community zeigt großes Interesse an Vertex Pharmaceuticals Inc. mit vielen Buy- und wenigen Sell-Einschätzungen.
Das Kursziel von 459 € für Vertex Pharmaceuticals Inc. impliziert eine leichte Steigerung gegenüber dem aktuellen Kurs von 433.75 €.
